Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christina Aquilante

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
30
2025
165
6.350
 Why?
Pharmacogenomic Testing
15
2025
60
4.390
 Why?
Thiazolidinediones
8
2016
137
2.660
 Why?
Aryl Hydrocarbon Hydroxylases
10
2014
48
2.320
 Why?
Heart Transplantation
9
2024
687
2.210
 Why?
Polymorphism, Genetic
17
2019
634
2.110
 Why?
Organ Transplantation
3
2024
247
1.730
 Why?
Cytochrome P-450 CYP3A
8
2024
88
1.620
 Why?
Precision Medicine
11
2025
415
1.570
 Why?
Genotype
20
2025
1872
1.490
 Why?
Polymorphism, Single Nucleotide
11
2024
2142
1.440
 Why?
Tacrolimus
3
2024
194
1.440
 Why?
Cytochrome P-450 CYP2C19
6
2024
25
1.350
 Why?
Health Personnel
4
2021
729
1.270
 Why?
Hypoglycemic Agents
11
2020
1298
1.250
 Why?
Transplant Recipients
6
2024
183
1.220
 Why?
Decision Support Systems, Clinical
2
2024
236
1.170
 Why?
Graft Rejection
3
2024
571
1.090
 Why?
Blood Pressure
8
2020
1786
1.070
 Why?
Metabolic Syndrome
4
2016
354
1.040
 Why?
Cytochrome P-450 CYP2D6
4
2022
30
1.000
 Why?
Pharmacists
3
2022
262
0.890
 Why?
Immunosuppressive Agents
6
2024
861
0.890
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2024
451
0.780
 Why?
Cost-Benefit Analysis
3
2024
578
0.770
 Why?
Gemfibrozil
2
2013
11
0.740
 Why?
Sulfonylurea Compounds
3
2018
49
0.710
 Why?
Leukopenia
1
2021
30
0.710
 Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
20
0.710
 Why?
Adiponectin
2
2016
243
0.710
 Why?
Hypolipidemic Agents
2
2013
91
0.700
 Why?
Warfarin
4
2024
154
0.690
 Why?
Mycophenolic Acid
1
2021
117
0.670
 Why?
Organic Anion Transporters
2
2011
10
0.670
 Why?
Desogestrel
5
2021
46
0.660
 Why?
Biological Specimen Banks
2
2024
100
0.660
 Why?
Platelet Aggregation Inhibitors
1
2024
465
0.650
 Why?
Humans
82
2025
136965
0.620
 Why?
Hypertension
3
2020
1299
0.620
 Why?
Prescription Drugs
2
2020
114
0.600
 Why?
Cytochrome P-450 CYP2C8
7
2014
14
0.590
 Why?
Cardiologists
1
2018
44
0.590
 Why?
Adult
43
2024
37715
0.590
 Why?
Middle Aged
41
2024
33226
0.580
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2021
46
0.560
 Why?
HIV Protease Inhibitors
4
2016
69
0.540
 Why?
Physicians
3
2021
921
0.540
 Why?
Ritonavir
4
2012
75
0.530
 Why?
Academic Medical Centers
1
2020
504
0.520
 Why?
Male
48
2024
67386
0.510
 Why?
Female
52
2024
73002
0.510
 Why?
Heart Failure
4
2017
2046
0.500
 Why?
Polypharmacy
1
2017
88
0.490
 Why?
Lectins
1
2016
46
0.490
 Why?
Nonprescription Drugs
1
2016
63
0.480
 Why?
Antiviral Agents
1
2021
757
0.460
 Why?
Attitude of Health Personnel
2
2020
1154
0.460
 Why?
Dihydrouracil Dehydrogenase (NADP)
2
2025
2
0.460
 Why?
Dihydropyrimidine Dehydrogenase Deficiency
2
2025
2
0.460
 Why?
Cytochrome P-450 Enzyme System
2
2006
155
0.440
 Why?
Medicare
1
2020
785
0.440
 Why?
Contraceptive Agents, Female
3
2020
78
0.440
 Why?
Death, Sudden, Cardiac
3
2021
183
0.430
 Why?
Pediatrics
2
2021
1061
0.420
 Why?
Chemokine CXCL5
3
2012
11
0.400
 Why?
Blood Pressure Determination
1
2014
160
0.400
 Why?
Arrhythmias, Cardiac
3
2021
326
0.400
 Why?
Heptanoic Acids
1
2013
66
0.390
 Why?
Anticoagulants
3
2024
652
0.380
 Why?
Pyrazines
1
2013
85
0.370
 Why?
Resistin
2
2010
11
0.370
 Why?
Pharmaceutical Preparations
3
2009
177
0.370
 Why?
Pravastatin
1
2011
41
0.370
 Why?
Pyrroles
1
2013
212
0.360
 Why?
Triazoles
1
2013
150
0.360
 Why?
Retrospective Studies
15
2024
15536
0.360
 Why?
Dobutamine
3
2008
26
0.350
 Why?
Diabetes Mellitus, Type 2
5
2020
2553
0.350
 Why?
Health Knowledge, Attitudes, Practice
4
2021
1365
0.350
 Why?
Cross-Sectional Studies
8
2020
5530
0.340
 Why?
Managed Care Programs
2
2022
141
0.330
 Why?
Aged
19
2024
23803
0.320
 Why?
Antidepressive Agents
2
2022
242
0.320
 Why?
Mixed Function Oxygenases
2
2008
46
0.310
 Why?
DNA
1
2016
1441
0.310
 Why?
Drug Interactions
5
2017
400
0.310
 Why?
Chromatography, Liquid
1
2010
437
0.290
 Why?
Polymerase Chain Reaction
3
2006
1045
0.290
 Why?
Drug Prescriptions
4
2021
258
0.280
 Why?
Health
1
2008
83
0.280
 Why?
International Normalized Ratio
2
2024
45
0.280
 Why?
Sulfonamides
1
2011
507
0.280
 Why?
Cytokines
1
2016
2070
0.280
 Why?
Chemokine CCL2
1
2008
116
0.280
 Why?
Antimetabolites, Antineoplastic
2
2025
92
0.270
 Why?
Time Factors
8
2020
6786
0.270
 Why?
Young Adult
13
2021
13218
0.270
 Why?
Receptors, Adrenergic, beta
1
2008
66
0.270
 Why?
Drug Implants
4
2021
81
0.270
 Why?
Mass Spectrometry
1
2010
737
0.270
 Why?
Heart Rate
3
2008
794
0.260
 Why?
Fluorouracil
2
2025
198
0.260
 Why?
Matrix Metalloproteinase 8
1
2006
8
0.260
 Why?
Haplotypes
5
2013
495
0.260
 Why?
Blood Glucose
3
2016
2184
0.260
 Why?
United States
12
2025
14945
0.260
 Why?
Sequence Analysis, DNA
4
2012
824
0.250
 Why?
Metoprolol
1
2006
21
0.250
 Why?
Vitamin K Epoxide Reductases
3
2020
12
0.250
 Why?
Prospective Studies
7
2024
7512
0.240
 Why?
Clinical Laboratory Techniques
1
2006
94
0.240
 Why?
Blood Coagulation Factors
1
2006
54
0.240
 Why?
Autonomic Nervous System
1
2006
79
0.240
 Why?
Electronic Health Records
3
2024
1087
0.240
 Why?
Models, Biological
1
2013
1780
0.230
 Why?
Administration, Oral
4
2016
783
0.230
 Why?
Clinical Protocols
2
2017
265
0.230
 Why?
Capecitabine
1
2025
41
0.230
 Why?
Echocardiography
1
2008
639
0.230
 Why?
Genetic Variation
3
2019
1000
0.220
 Why?
Adrenergic beta-Antagonists
1
2006
221
0.220
 Why?
Echocardiography, Stress
1
2004
23
0.220
 Why?
Cross-Over Studies
3
2013
547
0.220
 Why?
Polymorphism, Restriction Fragment Length
1
2004
66
0.220
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
77
0.220
 Why?
Carrier Proteins
1
2008
734
0.210
 Why?
Follow-Up Studies
5
2024
5048
0.210
 Why?
United States Food and Drug Administration
1
2024
200
0.210
 Why?
Biotransformation
2
2013
62
0.200
 Why?
Cohort Studies
7
2021
5688
0.200
 Why?
Cytochrome P-450 CYP2C9
4
2019
20
0.200
 Why?
Metformin
1
2007
336
0.200
 Why?
Alleles
6
2012
885
0.200
 Why?
Waist Circumference
2
2016
141
0.200
 Why?
Gene Frequency
4
2013
505
0.190
 Why?
Antimalarials
2
2013
31
0.180
 Why?
Dose-Response Relationship, Drug
4
2024
2015
0.180
 Why?
Clinical Trials as Topic
1
2006
1019
0.180
 Why?
Aged, 80 and over
5
2024
7559
0.180
 Why?
Drug Dosage Calculations
1
2020
22
0.170
 Why?
Calcineurin Inhibitors
1
2021
73
0.170
 Why?
Pharmacogenomic Variants
2
2021
33
0.170
 Why?
Egypt
1
2020
11
0.170
 Why?
Antibiotics, Antineoplastic
1
2021
123
0.170
 Why?
Cytomegalovirus
1
2021
157
0.170
 Why?
Atazanavir Sulfate
3
2016
43
0.160
 Why?
Area Under Curve
2
2013
303
0.160
 Why?
No-Show Patients
1
2019
1
0.160
 Why?
Menstruation Disturbances
1
2019
13
0.160
 Why?
Diabetes Mellitus
2
2024
1056
0.160
 Why?
Brain Chemistry
1
2000
114
0.160
 Why?
Hemodynamics
1
2004
1062
0.150
 Why?
Cytochrome P450 Family 3
1
2019
3
0.150
 Why?
Colorado
3
2024
4542
0.150
 Why?
Cardiovascular Diseases
3
2024
2115
0.150
 Why?
Blood Pressure Monitoring, Ambulatory
1
2020
87
0.150
 Why?
Oligopeptides
2
2012
269
0.150
 Why?
Smoking
1
2006
1609
0.150
 Why?
Body Weight
2
2016
985
0.150
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
348
0.150
 Why?
Morphine
1
2000
158
0.150
 Why?
Patients
1
2020
177
0.150
 Why?
Lipids
2
2016
678
0.150
 Why?
Child Health Services
1
2020
188
0.150
 Why?
Double-Blind Method
2
2016
1904
0.150
 Why?
Sitagliptin Phosphate
2
2021
32
0.140
 Why?
Progesterone
1
2019
255
0.140
 Why?
Ventricular Dysfunction
1
2018
15
0.140
 Why?
Treatment Outcome
7
2024
10664
0.140
 Why?
Bariatric Surgery
1
2021
215
0.130
 Why?
Body Mass Index
3
2019
2416
0.130
 Why?
Psychiatry
1
2020
184
0.130
 Why?
Apyrase
1
2017
17
0.130
 Why?
Pyridines
2
2012
497
0.130
 Why?
Healthy Volunteers
2
2019
202
0.130
 Why?
Organophosphonates
2
2008
95
0.130
 Why?
DNA Primers
3
2006
506
0.130
 Why?
Pyrophosphatases
1
2016
28
0.130
 Why?
Chronic Disease
2
2017
1774
0.130
 Why?
Cardiology
1
2018
271
0.120
 Why?
Anti-HIV Agents
2
2016
817
0.120
 Why?
Gene Expression Regulation, Enzymologic
1
2017
275
0.120
 Why?
GPI-Linked Proteins
1
2016
75
0.120
 Why?
Ribavirin
1
2016
94
0.120
 Why?
Patient Care
1
2016
112
0.120
 Why?
Circadian Rhythm
1
2020
474
0.120
 Why?
Depression
2
2022
1454
0.120
 Why?
Students, Pharmacy
1
2016
100
0.120
 Why?
Metabolic Clearance Rate
2
2013
107
0.120
 Why?
Adenine
2
2008
293
0.120
 Why?
Therapeutics
1
2015
13
0.110
 Why?
Voriconazole
1
2015
18
0.110
 Why?
Education, Pharmacy
1
2016
127
0.110
 Why?
HIV Infections
4
2016
2898
0.110
 Why?
beta-Cyclodextrins
1
2015
28
0.110
 Why?
Delivery of Health Care
1
2022
957
0.110
 Why?
Patient Education as Topic
1
2019
767
0.110
 Why?
Renal Replacement Therapy
1
2015
89
0.110
 Why?
Diltiazem
1
2014
19
0.110
 Why?
Surgical Procedures, Operative
1
2017
258
0.110
 Why?
Antifungal Agents
1
2015
132
0.110
 Why?
Phenotype
3
2024
3148
0.110
 Why?
Chromosomes, Human, Pair 10
1
2013
19
0.110
 Why?
Antigens, CD
1
2017
527
0.110
 Why?
Reoperation
1
2016
567
0.100
 Why?
Cardiomyopathies
1
2017
324
0.100
 Why?
Adolescent
6
2021
21471
0.100
 Why?
Kidney Transplantation
1
2019
696
0.100
 Why?
Medication Adherence
1
2017
489
0.100
 Why?
Half-Life
1
2013
143
0.100
 Why?
Venous Thromboembolism
1
2017
314
0.100
 Why?
Sirolimus
1
2014
268
0.100
 Why?
Tissue Distribution
2
2014
318
0.090
 Why?
Liver Transplantation
1
2019
841
0.090
 Why?
Darunavir
1
2011
19
0.090
 Why?
Practice Patterns, Physicians'
1
2020
1295
0.090
 Why?
Surveys and Questionnaires
2
2024
5812
0.090
 Why?
Self Care
1
2014
385
0.090
 Why?
Genetic Association Studies
1
2013
370
0.090
 Why?
Lung Transplantation
1
2014
312
0.090
 Why?
Acquired Immunodeficiency Syndrome
1
2012
232
0.080
 Why?
Reverse Transcriptase Inhibitors
2
2008
83
0.080
 Why?
Genetic Testing
2
2025
455
0.080
 Why?
Insulin Resistance
2
2010
1226
0.080
 Why?
Prevalence
1
2017
2732
0.080
 Why?
Patient Discharge
1
2016
901
0.080
 Why?
Cholesterol
1
2011
411
0.080
 Why?
Triglycerides
1
2011
525
0.080
 Why?
ATP-Binding Cassette Transporters
1
2010
119
0.080
 Why?
Leukocytes
2
2012
307
0.080
 Why?
Kidney Failure, Chronic
1
2015
569
0.080
 Why?
Lipoproteins
1
2010
166
0.070
 Why?
Longitudinal Studies
1
2016
2851
0.070
 Why?
Risk Assessment
3
2020
3446
0.070
 Why?
Lung Diseases
1
2014
767
0.070
 Why?
Databases, Factual
3
2021
1367
0.070
 Why?
Incidence
2
2020
2793
0.070
 Why?
Weight Gain
2
2021
535
0.060
 Why?
Indinavir
1
2006
7
0.060
 Why?
Drug Delivery Systems
1
2010
356
0.060
 Why?
Pyrimidinones
1
2007
112
0.060
 Why?
Linear Models
2
2019
857
0.060
 Why?
Genetic Techniques
1
2006
67
0.060
 Why?
Zidovudine
1
2006
77
0.060
 Why?
Lamivudine
1
2006
63
0.060
 Why?
Factor X
1
2006
27
0.060
 Why?
Prothrombin
1
2006
26
0.060
 Why?
Factor VII
1
2006
24
0.060
 Why?
Reproducibility of Results
1
2014
3266
0.060
 Why?
Drug Utilization
1
2007
169
0.060
 Why?
Chemokines, CXC
1
2006
69
0.060
 Why?
Base Sequence
2
2006
2168
0.060
 Why?
C-Reactive Protein
1
2008
413
0.060
 Why?
Biomarkers
3
2014
4095
0.060
 Why?
Oxidation-Reduction
1
2009
1073
0.060
 Why?
Prognosis
2
2014
3931
0.060
 Why?
Regression Analysis
1
2008
1007
0.060
 Why?
Delayed-Action Preparations
1
2006
173
0.060
 Why?
Pharmacovigilance
1
2024
23
0.060
 Why?
Health Care Surveys
1
2007
564
0.060
 Why?
Mathematical Computing
1
2004
10
0.060
 Why?
Gene Expression Regulation
1
2014
2574
0.060
 Why?
Gene Expression
1
2009
1480
0.050
 Why?
Drug Labeling
1
2004
38
0.050
 Why?
Risk Factors
3
2020
10363
0.050
 Why?
Infusions, Intravenous
1
2004
392
0.050
 Why?
Multidrug Resistance-Associated Proteins
3
2008
34
0.050
 Why?
Laboratories
1
2004
108
0.050
 Why?
Algorithms
3
2024
1700
0.050
 Why?
Reference Values
1
2004
797
0.050
 Why?
Kidney
2
2008
1466
0.050
 Why?
Drug Monitoring
1
2024
208
0.050
 Why?
Blood Coagulation
1
2024
255
0.050
 Why?
Socioeconomic Factors
1
2007
1310
0.050
 Why?
Linagliptin
1
2021
5
0.050
 Why?
Adamantane
1
2021
17
0.050
 Why?
Administrative Claims, Healthcare
1
2021
25
0.040
 Why?
Dipeptides
1
2021
49
0.040
 Why?
Electronic Prescribing
1
2021
3
0.040
 Why?
Electrocardiography
1
2004
607
0.040
 Why?
Uterine Hemorrhage
1
2021
38
0.040
 Why?
Protective Factors
1
2020
94
0.040
 Why?
Costs and Cost Analysis
1
2020
208
0.040
 Why?
Drug Tolerance
1
2000
102
0.040
 Why?
Treatment Failure
1
2020
338
0.040
 Why?
Homozygote
2
2012
203
0.040
 Why?
Animals
3
2008
36882
0.040
 Why?
Kaplan-Meier Estimate
1
2021
868
0.040
 Why?
Sex Factors
1
2024
2060
0.040
 Why?
Genomics
1
2024
804
0.040
 Why?
Attitude
1
2020
262
0.040
 Why?
Glipizide
1
2018
6
0.040
 Why?
Antineoplastic Agents
1
2009
2111
0.040
 Why?
Proportional Hazards Models
1
2021
1251
0.040
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.040
 Why?
Glyburide
1
2018
32
0.040
 Why?
Liver
1
2006
1867
0.030
 Why?
Dexamethasone
1
2000
359
0.030
 Why?
Social Class
1
2019
282
0.030
 Why?
Feasibility Studies
1
2021
965
0.030
 Why?
Self-Management
1
2019
181
0.030
 Why?
Self Report
1
2021
836
0.030
 Why?
Membrane Transport Proteins
2
2008
150
0.030
 Why?
Anesthetics
1
2017
80
0.030
 Why?
Peru
1
2016
60
0.030
 Why?
Pharmaceutical Services
1
2016
85
0.030
 Why?
Diabetic Angiopathies
1
2018
260
0.030
 Why?
Tenofovir
2
2008
268
0.030
 Why?
Cause of Death
1
2018
428
0.030
 Why?
Medicaid
1
2020
437
0.030
 Why?
Perioperative Care
1
2017
177
0.030
 Why?
South Africa
1
2016
226
0.030
 Why?
Indians, North American
1
2021
655
0.030
 Why?
Alternative Splicing
1
2017
226
0.030
 Why?
Preoperative Care
1
2017
348
0.030
 Why?
HEK293 Cells
1
2017
727
0.030
 Why?
Hepatitis C, Chronic
1
2016
164
0.030
 Why?
Rats, Sprague-Dawley
1
2000
2463
0.030
 Why?
Receptors, Steroid
1
2014
46
0.030
 Why?
Everolimus
1
2014
88
0.030
 Why?
Demography
1
2014
295
0.030
 Why?
Hypoglycemia
1
2018
443
0.020
 Why?
Vasodilator Agents
1
2014
319
0.020
 Why?
Age Factors
1
2019
3258
0.020
 Why?
Mental Disorders
1
2020
1089
0.020
 Why?
Heterozygote
1
2012
305
0.020
 Why?
Rats
1
2000
5544
0.020
 Why?
Genetic Loci
1
2012
283
0.020
 Why?
Neoplasms
1
2024
2698
0.020
 Why?
Insulin
1
2019
2394
0.020
 Why?
Critical Illness
1
2015
789
0.020
 Why?
Multivariate Analysis
1
2012
1484
0.020
 Why?
Genetic Predisposition to Disease
1
2017
2371
0.020
 Why?
Body Composition
1
2012
690
0.020
 Why?
Plasma
1
2009
215
0.020
 Why?
Lopinavir
1
2007
30
0.020
 Why?
PubMed
1
2006
11
0.020
 Why?
Ribosomal Proteins
1
2006
91
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2007
276
0.010
 Why?
Pharmacology
1
2005
10
0.010
 Why?
Molecular Sequence Data
1
2009
2900
0.010
 Why?
Likelihood Functions
1
2005
143
0.010
 Why?
RNA, Messenger
1
2012
2788
0.010
 Why?
Cardiotonic Agents
1
2005
91
0.010
 Why?
Mitochondrial Proteins
1
2006
257
0.010
 Why?
Chromosome Mapping
1
2005
514
0.010
 Why?
Genome
1
2006
300
0.010
 Why?
Drug Therapy, Combination
1
2006
1022
0.010
 Why?
Hemorrhage
1
2008
717
0.010
 Why?
Predictive Value of Tests
1
2008
1999
0.010
 Why?
Saccharomyces cerevisiae Proteins
1
2006
401
0.010
 Why?
Models, Genetic
1
2005
586
0.010
 Why?
Pilot Projects
1
2006
1730
0.010
 Why?
Child
1
2020
21760
0.010
 Why?
Computer Simulation
1
2005
982
0.010
 Why?
Case-Control Studies
1
2007
3556
0.010
 Why?
Inflammation
1
2006
2831
0.010
 Why?
Aquilante's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)